Repositioning of clinically approved drug Bazi Bushen capsule for treatment of Aizheimer's disease using network pharmacology approach and in vitro experimental validation-Reference-Cited by-同舟云学术

Repositioning of clinically approved drug Bazi Bushen capsule for treatment of Aizheimer's disease using network pharmacology approach and in vitro experimental validation

Published:2023-07 Issue:7 Volume:9 Page:e17603
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Wang Tongxing^ORCID,Chen Meng,Li Huixin,Ding Guoyuan,Song Yanfei,Hou Bin,Yao Bing,Wang Zhixin,Hou Yunlong,Liang Junqing,Wei Cong,Jia Zhenhua

Funder

Hebei Province Health Commission

Hebei Province Science and Technology Support Program

Chinese Academy of Engineering

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference64 articles.

1. Repurposing drugs to treat cardiovascular disease in the era of precision medicine;Abdelsayed;Nat. Rev. Cardiol.,2022

2. Integration strategy of network pharmacology in Traditional Chinese Medicine: a narrative review;Jiashuo;J. Tradit. Chin. Med.,2022

3. Network pharmacology;Hopkins;Nat. Biotechnol.,2007

4. Network pharmacology: the next paradigm in drug discovery;Hopkins;Nat. Chem. Biol.,2008

5. Network-based drug repositioning: a novel strategy for discovering potential antidepressants and their mode of action;Zhang;Eur. Neuropsychopharmacol,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bazi Bushen capsule attenuates cardiac systolic injury via SIRT3/SOD2 pathway in high-fat diet-fed ovariectomized mice;Heliyon;2024-06

2. Mechanism of Bazi Bushen capsule in delaying the senescence of mesenchymal stem cells based on network pharmacology and experimental validation;Heliyon;2024-03

3. Liposomal α-cyperone targeting bone resorption surfaces suppresses osteoclast differentiation and osteoporosis progression via the PI3K/Akt axis;Nano Research;2023-10-31